Skip to main content
Caplight Logo









Prevencio, Inc.

Prevencio, Inc.

Private
Kirkland, WashingtonHealthcare & Life Scienceshttps://prevenciomed.com/

Last Round

Accelerator

May 29, 2024

Total Funding Raised

$24.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Prevencio, Inc. is a biotechnology company that develops AI-driven, multi-protein blood tests for the diagnosis and risk assessment of cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

precision medicinecardiovascular diagnosticsbiomarker testingmedical AIproteomicsAI diagnosticsclinical decision supportrisk stratificationblood-based diagnosticsdiagnostic algorithmdigital healthbiotechclinical laboratory servicesAI-driven medicinemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prevencio, Inc. Comparables

Compare Prevencio, Inc. with similar companies based on industry and business-model similarity.

Prevencio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prolocor
79%
Zora Biosciences
78%
numares Health
77%

Prevencio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 29, 2024
Series B ExtensionMar 1, 2022
AcceleratorOct 17, 2019
DebtAug 19, 2019
Series BJun 30, 2016
Series B
Mar 23, 2016

Key People

Founding team and executive leadership

Michele McCarthy

Chief Financial Officer, Member Board of Directors

Executive Team

Prevencio, Inc. Investors

Notable investors and investment history

Prevencio, Inc. investors
InvestorRounds
MedTech InnovatorAccelerator
Bayer G4AAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 178% to 6.3K.

  • Jan 20, 2026

    Monthly visitors increased 46% MoM, reaching 1.4K.

Prevencio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prevencio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prevencio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKirkland, Washington
Employee Range9
Year Founded2006
Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?